Sources Listing Archive
Archived Listing - Last Updated: September 2011. This information represents a historical archive of listings which appeared in SOURCES, which has been continuously published in print and online since 1977. The information has not been updated since the date indicated. For current information consult the SOURCES website at www.sources.com. To be included in the current SOURCES listings, and to take advantage of other tools including unlimited news releases and event calendar postings, fill out the online membership form. For more information, see Frequently Asked Questions or call 416-964-7799.
Cameron Durrant, MD, MBA, is the Executive Chairman of the Board of Anavex Life Sciences Corp. ("ANAVEX") (AVXL:OB), a biopharmaceutical company engaged in the discovery and development of novel drug candidates for the treatment of neurological diseases (Alzheimer's disease, epilepsy and pain) and various types of cancer. The company has developed a rich portfolio of drug candidates using its proprietary drug discovery SIGMACEPTOR platform and is currently in Phase I clinical trials with its lead drug candidate, a disease-modifying, first-of-a-new-class compound for the treatment of Alzheimer's disease.
Dr. Durrant has a unique entrepreneurial background coupled with almost 20 years of international pharmaceutical and biotech experience. He has held executive positions at both specialty and major global pharmaceutical companies, including Merck & Co., GlaxoSmithKline, Pharmacia Corporation (now part of Pfizer, Inc.) and Johnson & Johnson. He is a serial entrepreneur, CEO and Board member.
Dr. Durrant is an experienced media guest (radio, print, online and industry press). He can discuss all aspects of the drug development-commercialization-value creation process (both clinical trials and business considerations), particularly in relation to Alzheimer's disease, other neurological diseases, cancer and infectious diseases. He is highly skilled at making technical topics easy to understand for a general audience.
Areas of Expertise:
For information or updates contact Sources at 416-964-7799
or see our current publications and services online:
© Sources 1977-2012. The information provided
is copyright and may not be reproduced in any form or by any means (whether
electronic, mechanical or photographic), or stored in an electronic
retrieval system, without written permission of the publisher. The content
may not be resold, republished, or redistributed. Indexing and search applications by Ulli Diemer and Chris DeFreitas.